Israel Study Says Pfizer Vaccine Is Very Effective in Real-World Use

The New York Times | Feb. 24, 2021, 5:50 p.m. | Original

A huge study in Israel found that the vaccine reduced symptomatic cases by 94 percent a week after the second dose, and reduced severe disease by 92 percent.

Facing Roadblocks, Vast Global Vaccination Effort Gets Underway California has passed the 50,000-death mark, the most of any state.